Palvella Therapeutics's market cap is currently $235.54M. The company's EPS TTM is $-12.611; its P/E ratio is ―; Palvella Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 42.81M	$ 25.90M	$ 31.42M	$ 29.32M	$ 46.28M
Gross Profit	$ 1.01M	$ 23.12M	$ 29.05M	$ -17.21M	$ -8.72M
Operating Income	$ -29.76M	$ -43.47M	$ -51.83M	$ -33.92M	$ -27.16M
EBITDA	$ -22.76M	$ -30.50M	$ -43.37M	$ -31.61M	$ -26.12M
Net Income	$ -24.54M	$ -31.25M	$ -43.37M	$ -37.23M	$ -23.75M
Balance Sheet
Cash & Short-Term Investments	$ 26.37M	$ 59.17M	$ 117.76M	$ 70.44M	$ 104.15M
Total Assets	$ 38.68M	$ 95.49M	$ 153.56M	$ 105.01M	$ 141.10M
Total Debt	$ 0.00	$ 13.10M	$ 13.84M	$ 16.96M	$ 16.22M
Net Debt	$ -17.40M	$ -25.53M	$ -103.92M	$ -53.47M	$ -46.04M
Total Liabilities	$ 11.92M	$ 67.56M	$ 102.81M	$ 73.98M	$ 89.75M
Stockholders' Equity	$ 26.76M	$ 27.93M	$ 50.76M	$ 31.03M	$ 51.35M
Cash Flow
Free Cash Flow	$ -53.99M	$ -60.97M	$ -8.61M	$ -48.62M	$ -54.93M
Operating Cash Flow	$ -53.82M	$ -59.93M	$ -7.66M	$ -45.90M	$ -52.47M
Investing Cash Flow	$ 12.00M	$ -21.24M	$ -949.00K	$ 39.21M	$ 9.84M
Financing Cash Flow	$ 19.80M	$ 7.21M	$ 59.13M	$ 10.12M	$ 32.17M

Currency in USD

Palvella Therapeutics Earnings and Revenue History

Income Statement >

Palvella Therapeutics Debt to Assets

Balance Sheet >

Palvella Therapeutics Cash Flow

Cash Flow >

Palvella Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing